Клинический случай циркуляции антифосфолипидных антител у пациентки с привычным невынашиванием беременности и злокачественным новообразованием легкого

КЛИНИЧЕСКИМ СЛУЧАИ ЦИРКУЛЯЦИИ АНТИФОСФОЛИПИДНЫХ АНТИТЕЛ У ПАЦИЕНТКИ С ПРИВЫЧНЫМ НЕВЫНАШИВАНИЕМ БЕРЕМЕННОСТИ И ЗЛОКАЧЕСТВЕННЫМ НОВООБРАЗОВАНИЕМ ЛЕГКОГО

ООО "КДМ "ЮНОНА1, ул. Еременко далд. 25/36, Роег№на-Дону, Ростовская область, Российская федерации, 344041

й синдром, развитием

неская целость выявления циркуляции антифосфолипидных : с отягощенным акушарскогинекологичаским анамнезом, в при пвдтаерждеыии внтифософлипидного ошдромл (АФС). Кроме лабораторных тестах на АФЛ при ■

Дм цкпфоаашииКаплинаЕ-НКлтический случай циркуляции антифосфолипидных антител у пациент*« с привычным

N«3. С-16-24. dot .10244,12/037091 -2023-3-1S-24

CIRCULATING ANTI PHOSPHOLIPID ANTIBODIES IN A PATIENT WITH RECURRENT PREGNANCY LOSS AND LUNG CANCER: A CASE REPORT

EkattfiiaN.Kapllna

LLC KDM ■yUMONA'.&Emente) rtr, 25/3fi, Roetav-№Oon, Raster region, Ruasian Federation

(d syndrome, lung сапсан and clrcUaOng antlphoaphoWd

'Г,

I

IS

ti

il

H

Щ

I Щ,

IlEïi ïSï

Информация об авторе

Каплнна Екатерина Николаевна, к.м,н., врач-терапевт, гемоетааиолог, главный врач МЦ "Юнона", г. Раетоа-на- Дону, Российская Федерация ORCO: 0000-0003-0382-7688

Buttering N. Kaplhia, Candidate of Medical Sciences, MD, chief physician of the medical center "Junona", Rostovron-Don, Russian Federation ORCD: 0000-0003-0382-7688

Список литературы

L Mlyakls S., Lockahln M.D., Atsuml Т., et aL International consensus statement on an update of the classification criteria tor definite antiphospholipid syndrome (APS) // J Thromb HaemoaL 2006. Vol. .4, №2. P. 295-306, dot 1йП11ЛЛ538-783&200аЛ175Эл

2. Jayakody Arachchlllaee D., Greaves M. The chequered history of the antiphospholipid syndrome // Br J HaematoL 2014. VOL .165, №5. P. 609-17. dob 10.1111/bjh.l2848

3. Devraeae К. M. J., da Oroot P. 0, da Laat B, at aL Guidance from the Scientific and Standardization Committee for lupus amiooagulant/antiphosphoipid antibodies of die International Society on Thrombosis and Haemostasia. Update of the guidelines for lupus anticoagulant detection and interpretation // J Thromb HaemosL 2020, No 18, P. 2828-2839. dot 10,1111/ Jth.15047

4. Barbhalya M., Zully S-, Naden R, et aL ACR/EULAR APS Classification Criteria Collaborator*. 2023 ACR/EULAR antlphosphollpld syndrome classification criteria // Am Rheum Из. 202a VoL 82, №10. P. .1258-1270. dot 10.1136/ ard-2023-22480S

5. Pengo V-, Ruffatti A, Legnani C., et aL Incjderce of a IVst thromboembolic event In asymptomatic carriers of high-risk antlphoaphollpld antibody profki a multlcenter prospective study // Blood 2011 Vol. 118, №17. P. 4714-8. dot .10.1182/blOOd -201.1.-03-3.40232

6. Krishna M BaradhL Narothama Raddy Aeddula, Antlphosphollpld antibody syndrome. FACP, FASN The 5-minuta Clinical Consult 2021,29th edition, Woltars Kluwar

7. Vila P., Hernández M.C, Lápez-Fernández MJ, at aL Prevalence, follow-up and clinical significance of the antlcardlolpln antibodies to normal subjects II Thromb HaemosL 1994. VoL 72, №2. P. 209-213.

a Tarahorelli M, Leuenberger L, Lazzaroni M.G-, at aL The conulbutlon of antlphosphollpld antibodies to organ damage In systemic lupus erythematosus II Lupus. 2018. VoL 25, N»12. P. 1385-a. dot .10.1177/0981203318837431 9 McNeil HJ>., Chester man СЛ., Krilis SA. Immunology and clinical Importance of ant^jhosphollptd antlbodlas U Adv ImmunoL .1091 No 49. P. .193-280, dot .10,1.0.10/ 60085-2778108)80777-4

10. Cervera R., Asherson RA. Clirical and epidemiological aspects In the antlphosphollpld syndrome U Immunoblology. 2003. VoL 207, N».1. P. 5-11 dol: 10.1078/0171 -2985-00213

.1.1 Vassalo J, Spector N, de Mels E, et aL Antlphosphollpld antibodies In critically 111 patients with career: a prospective cohort study // J Grit Care. 201.4. VOL 29, №4. P. 533-8. dol: 10.101 e¿)crcJ014.Q2.005

12. Nlpu MAX, Kundu S., Alam S.S, « aL Antlcardlollpln Antibodies In Patients with Cancer; A Case-Control Study, Cancers (Basel). 2023. VoL 15, №7. P. 2087. doi: .10.3390/ canceral5072087

13. Kansuttlvlwat C., Nlprapan P, Tanthvorawlt A, at aL Intact of antfchoaplwllptd antibodies on thrombotic events in ambulatory cancer patients // PLoS One. 2023. VOL 18, №4. P. »0279.450. dot .1.0,137.1/ JournaLpone.0278450

14. Клинические рекомендации Министерства здравоохранения Российской федерации 2022 года «Привычный выкидыш»

15. Taktonldou МО, Andreoll 1_ Llmpar M, at aL EULAR recommendations for the management of amiphospholipid syndrome in adults // Ann Rheum Die. 2019. VoL 78, №10. P. .1296.-1304. dot 10,1.138/

16. Wang Tï4 Zwlcker -LL, Ay C, et aL The use of direct oral anticoagulants for primary thromboprophylaxis in ambulatory cancer patienta: Guidance from the SSCof the 1STH II J Thromb Haemost 2019. VOL .17, N»10, P. .1772-1778. dob I0.1.11l/}th.l4584

17. Khorana AA, Kuderer NJA, Ctiakova E, et aL Development and validation of a predictive model for chemotherapy-associated thrombosis II Blood, 2008. VOL .1.1.1, N«10. P. 4902-4907. doi: 10.1182/ blood-20O7.-.1O-.11B327

18. Сомоноаа CLB, Антух ЗА, Варданян АЛ, и др. Практические рекомендации по профилактике и лечению тромбоамботачееких осложнений у онкологических Вольных. Злокачаства«4ыв опухоли:

№3в2. С. 158-170.

19. Abrlol Razak N.B., Jones G., Bhandari M, at aL Cancar-Aasoclated Thrombosis: An Overview of Mechanisms, Risk Factors, and Treatment. Cancers (Basel). 2018. VoL .1.0, №10. P. 380. doi: m390/oaneers10100380

20. Pengo V, Ruffatti A, Legnani C, at aL Incidence of a first thromboembolic event In asymptomatic carriers of high-risk antlphosphollpld antibody profile: a multlcenter prospective study Ц Blood. 201L VoL 118, »17. P. 4714-

4718. dot 10.1ia2/bload-20l1-03-S40232

21. Pisters H, Lane D.A, Nieuwlaat li, at aL A nova) usar-ftlendly score (HAS-BLED) to assess 1-year risk of major bleeding In patients with atrial fibrillation: the Eus Heart Survey II Chest 20.10. VOL 138, №5. P. 1003-100. dot .1D.1378/Chastl0.-0.134

22. PalaretJ G-, Antonuccl E., Mastrolacovo D-, at aL .The American Collage of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism II Thromb HaemosL 20.1a VoL .18, №10. P. 1994-2002. dot 10.mi/Jth.14253

23. Klok FA, Barco 5, Konstantlnldes S.V. External validation of the VTE-BLEED score for predicting in stable

antlcoagulated patients with venous thromboembolism // Thromb Haemost 2017. Ho. 117. P. 1184-1170.

24. Rulz-Gknénez N., Suárez С., González R, at aL Predictive variables for major bleeding events In patients presenting with documented acute venous thromboembolism. Findings from the ИЕТЕ Registry II Thromb Haemost 2008. VoL 100, W.1. P. 28.-31. dOfc10.l160/TH08-03-0193

25. American Thoracic Society. Implementation guide for lung cancer screening [дата обращения; 11 ноября 2023 года]. Доступно по ссылке; httpK// wwwJungcancarscreanlngguldftorg/

1. Mlyakbs S, Lockshln MD, Atsuml T, et al consensus statement on an update of the classification criteria for definite antlphosphollpld syndrome (APS). J Thromb Haemost 2008^(2)Л95"30& dot .10.1.1.11/

eaves M. The chequered history of the antlphosphollpld syndrome. Br J Haematol 2014,185(51:808-17. dot iai.1.1.1/bjh.12848

et P6, de Laat B, et aL Ci

19. dot 10.111.1/Jth.15Q47

a FACP, FASN The 5-

mlnute Clinical Consult 2021,29th edition, Walters KUwar 7. Vila P, Hernández MC, Lápaz-Femárdaz MF, at aL

IB. dot 10.1.177/096.120331663743.1 9. McNeil HP, Chastarman CN, Krills SA. Immunology and

10. Cervera R, Asherscn RA. Clinical and epidemiological aspects In the antlphosphollpld

Immunobtotoay. 20032Q7fllS-.11.

10.1078/0171-2985-00213

11. Vassalo J, Spector N, de Mels E,etaL Antlphosphollpld antibodies In critically III patients with cancer: a prospective cohort study. J Crtt Care. 2014^9(41:533-538. dot.10.10.18flicrcJ2Ql40)2.00S

12. Nlpu MAI, Kundu S, Alam SS, et aL Antlcardloipln Antibodies In Patients with Cancer: A Case-Control Study. Cancers ¡Basel). 2023^5(71:2087. dot 10.3390/ careersl 5072087

13. Kansuttlvlwat C, Nfcrapan P, Tartlworawlt A, et at Impact of antlphosphollpld antibodies on thrombotic events In ambulatory cancer patients. PtoS One. 2023;1B(1te0279450. dot .lO.137.1flournaLponeJM78450

14. KUnicheskie rekomendacll MInlsterst<ra zdravoohranenlya Rossljsko] Federacl 2022 goda •Prtvychny] vykldysft«.

MG, Andre olí L,

d syndrome In adults. Ann Rheum Dfa. 98-1304. dot 10.1138/

annrheumdIs-2019-215213

16. Wang TF, Zwlcker 41, Ay C, et at The use of direct oral for primary thromboprophylaxis In is: Quittance from the SSC of the ISTR J Thromb Haemost 2019fl7(10W772-177a dot 10.11.11/Jth.1.4564

Culakova E, at aL predictive model for thrombosis. Blood. dot 10.1182/

i OV, Antuh EA, Vardanyan AV, at aL e rekomendacll po pnjfllaktlke I lechenlyu oslozhnenq u onkologlchesklh prakHcheSde

rekomendacll RUSSCQ. 2022;12t3s2):158^l70. 19. Abdol Razafc NB, Jones G, Bhandari M, et at Cancer-

Associated Thromhosis: An Overview of Mechanisms, Risk Factors, and Treatment. Cancers (Sassy. 2018^0(101:380. dot 10.3380/cancerel 0100380

20. Pengo V, RuffattJ A, Leananl C, et al Incidence of a Ira thromboembolic avent in asymptomatic carriers of high-risk antlphosphollpld antibody profie: a multlcantar prospective study. Stood. 201U118(17):4714-47ia dot 1 aiia2/bicod-20i 1 -03-340232

21. Pister» R, Lane DA, Nieuwlaat R, at al. A novel user-filendly score (HAS-BLED) to assess 1-year risk of major bleeding In patients with atrial fibrillation: the Euo Heart Survey. Chest 20tO,iaa(5):.1Q93-.1Qa dot 10.1378/ chest10.-013.4

22. Palaretl G, Antoruccl E, Mastrolacovo D, at al. The American Collage of Chest Physician score to assess the risk of bleeding during anticoagulation ri patients with

venous thromboembolism. Thromb HSamost

2018,16 (10}:1994-2002. dot .10.111lfltll.14253

23. Klok FA, Barco S, KonstantWdes SV, External

validation of the VTE-BLEED score for predicting major

bleeding In stable antlcoagulatad patients with venous

thromboembolism. Thmmb Haamoat. 2017; .1175

.1184-1170.

2d. Rub-Glminez N, Suärez C, Gonzilez R, et at Predictive variables for major bleeding events In patients presenting with documented acuta venous thromboembolism. Findings from .the RIETE Registry. Thromb HaamosL 2008;100i1>.-26.-3l dotlO.1.160/ .TH08.-0.3.-.0.193

25. Amerlcen Thoracic Society. Implementation guide for lung cancer screening Idted 2023 November .11]. Available from: httpsJ/wwwJungcancarscreen*TgguIda.org/

Аннотация научной статьи по клинической медицине, автор научной работы — Каплина Екатерина Николаевна

Похожие темы научных работ по клинической медицине , автор научной работы — Каплина Екатерина Николаевна

CIRCULATING ANTIPHOSPHOLIPID ANTIBODIES IN A PATIENT WITH RECURRENT PREGNANCY LOSS AND LUNG CANCER: A CASE REPORT